Inventor · disambiguated record
Hans-Harald Sedlacek
Also filed as: JOHANNSEN ROLOFF · SEDLACEK HANS H · SEDLACEK HANS-HARALD
50 granted patents·14 pending applications·1,487 citations·filing 1976–2009
99Inventor score
Top patents by PatentIndex Score
64 records- 0199US5830880AGene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compoundHOECHST AG·Filed 1995·Granted Nov 3, 1998·351 cites·52 claims
- 0294US5284856AOncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivativesHOECHST AG·Filed 1992·Granted Feb 8, 1994·87 cites·3 claims
- 0391US6759518B1Single-chain multiple antigen-binding molecule, its preparation and useVECTRON THERAPEUTICS AG·Filed 1999·Granted Jul 6, 2004·108 cites·19 claims
- 0490US5561119AGlycosylated prodrugs, their method of preparation and their usesHOECHST LAB·Filed 1992·Granted Oct 1, 1996·107 cites·36 claims
- 0587US7838637B2Single-chain multiple antigen-binding molecule, its preparation and useAFFITECH RES AS·Filed 2004·Granted Nov 23, 2010·22 cites·20 claims
- 0686US4578399AUse of the diterpene derivative forskolin for immunostimulationHOECHST AG·Filed 1984·Granted Mar 25, 1986·26 cites·4 claims
- 0783US6548067B1Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereofFiled 1995·Granted Apr 15, 2003·47 cites·10 claims
- 0883US5079263AManumycin derivatives and the use thereofBEHRINGWERKE AG·Filed 1988·Granted Jan 7, 1992·38 cites·5 claims
- 0982US5916803ATarget cell-specific non-viral vectors for inserting genes into cells, pharmaceutical compositions comprising such vectors and their useHOECHST AG·Filed 1997·Granted Jun 29, 1999·60 cites·11 claims
- 1081US6482618B2Self-enhancing, pharmacologically controllable expression systemsAVENTIS PHARMA GMBH·Filed 2002·Granted Nov 19, 2002·11 cites·17 claims
- 1181US4479934AMethod and agent for the therapy of immunocomplex diseasesBEHRINGWERKE AG·Filed 1979·Granted Oct 30, 1984·18 cites·1 claims
- 1281US4332783AProcess for immunologic determination testsBEHRINGWERKE AG·Filed 1979·Granted Jun 1, 1982·43 cites·10 claims
- 1381US4157383ATanned thrombocytesBEHRINGWERKE AG·Filed 1976·Granted Jun 5, 1979·35 cites·7 claims
- 1477US6670147B1Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and useAVENTIS PHARMA GMBH·Filed 1999·Granted Dec 30, 2003·39 cites·7 claims
- 1577US5854019ACell-specific gene therapy using as promoter novel promoters for tissue inhibitors of metalloproteinase-3HOECHST AG·Filed 1996·Granted Dec 29, 1998·48 cites·16 claims
- 1674US6495346B1Complex-forming proteinsAVENTIS PHARMA GMBH·Filed 2000·Granted Dec 17, 2002·10 cites·12 claims
- 1774US6080575ANucleic acid construct for expressing active substances which can be activated by proteases, and preparation and useHOECHST AG·Filed 1998·Granted Jun 27, 2000·28 cites·22 claims
- 1873US7662383B2Chimeric antibody against tumor associated antigens and its use in diagnosing tumorsAVENTIS PHARMA GMBH·Filed 2008·Granted Feb 16, 2010·0 cites·8 claims
- 1973US5885833ANucleic acid constructs for the cell cycle-regulated expression of genes and therapeutic methods utilizing such constructsHOECHST AG·Filed 1997·Granted Mar 23, 1999·37 cites·19 claims
- 2071US4762848A1,3-thiazoles and their use as immunomodulatorsHOECHST AG·Filed 1986·Granted Aug 9, 1988·10 cites·18 claims
- 2169US4699912AUse of Lycorine as an immunosuppressorBEHRINGWERKE AG·Filed 1985·Granted Oct 13, 1987·14 cites·3 claims
- 2268US5519018ASubstituted phenols and their use for the treatment of disorders caused by cell proliferationBEHRINGWERKE AG·Filed 1995·Granted May 21, 1996·29 cites·11 claims
- 2367US4603137AImmunosuppressive chromone alkaloidHOECHST AG·Filed 1984·Granted Jul 29, 1986·11 cites·2 claims
- 2466US6926896B2Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereofAVENTIS PHARMA GMBH·Filed 1994·Granted Aug 9, 2005·17 cites·10 claims
- 2566US4762648AMonofunctional and bisfunctional anthraquinone-(oxy-2,3-oxidopropanes), processes for their preparation, and their use as drugsHOECHST AG·Filed 1984·Granted Aug 9, 1988·9 cites·6 claims
- 2666US4510129AImmunostimulating agentHOECHST AG·Filed 1982·Granted Apr 9, 1985·11 cites·6 claims
- 2765US6380170B1Nucleic acid construct for the cell cycle regulated expression of structural genesAVENTIS PHARMA GMBH·Filed 1998·Granted Apr 30, 2002·25 cites·16 claims
- 2864US8313751B2Compositions and methods for the prophylaxis or treatment of viral diseasesPLANZ OLIVER·Filed 2008·Granted Nov 20, 2012·1 cites·5 claims
- 2964US7241595B2Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugatesSANOFI AVENTIS PHARMA DEUTSCHL·Filed 2002·Granted Jul 10, 2007·1 cites·20 claims
- 3064US6358524B1Target cell-specific non-viral vectors for inserting genes into cells, pharmaceutical compositions comprising such vectors and their useAVENTIS PHARMA GMBH·Filed 1999·Granted Mar 19, 2002·17 cites·9 claims
- 3164US2006159682A1Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereofAVENTIS PHARMA GMBH·Filed 2004·Application pending·0 cites
- 3262US6475486B1Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugatesAVENTIS PHARMA GMBH·Filed 1999·Granted Nov 5, 2002·13 cites·6 claims
- 3362US6384202B1Cell-specific active compounds regulated by the cell cycleHOECHST AG·Filed 1995·Granted May 7, 2002·14 cites·23 claims
- 3462US6358732B1DNA for expression under control of a cell cycle-dependent promoterAVENTIS PHARMA GMBH·Filed 1995·Granted Mar 19, 2002·14 cites·16 claims
- 3562US6235526B1Nucleic acid constructs containing genes encoding transport signalsAVENTIS PHARMA GMBH·Filed 1997·Granted May 22, 2001·18 cites·49 claims
- 3661US6033856APromoter of the cdc25B gene, its preparation and useHOECHST AG·Filed 1998·Granted Mar 7, 2000·19 cites·43 claims
- 3761US2009326206A1Single-chain Multiple Antigen-binding Molecule, Its Preparation and UseKONTERMANN ROLAND·Filed 2009·Application pending·0 cites
- 3860US6383785B1Self-enhancing, pharmacologically controllable expression systemsAVENTIS PHARMA GMBH·Filed 1997·Granted May 7, 2002·12 cites·12 claims
- 3958US2004110682A1Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and useFiled 2003·Application pending·0 cites
- 4057US6576758B1Nucleic acid constructs containing hybrid promotersAVENTIS PHARMA GMBH·Filed 1997·Granted Jun 10, 2003·15 cites·17 claims
- 4156US6465246B1Oncogene- or virus-controlled expression systemsAVENTIS PHARMA GMBH·Filed 1998·Granted Oct 15, 2002·11 cites·2 claims
- 4256US5643731AUse of pairs of leucine zipper peptides in immunoassay methodsBEHRINGWERKE AG·Filed 1995·Granted Jul 1, 1997·21 cites·14 claims
- 4356US4713371AAnthracycline derivatives and their use as cytostaticsHOECHST AG·Filed 1986·Granted Dec 15, 1987·9 cites·12 claims
- 4455US2004091488A1Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereofKLAUS BOSSLET DR·Filed 2003·Application pending·0 cites
- 4554US5006515APharmaceuticals, phosphorus-containing 2-isoxazolines and isoxazoles contained thereinHOECHST AG·Filed 1988·Granted Apr 9, 1991·7 cites·11 claims
- 4654US2009155270A1Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenzaACTIVAERO GMBH·Filed 2008·Application pending·0 cites
- 4753US6265562B1Nucleic acid constructs whose activity is affected by inhibitors of cyclin-dependent kinases and uses thereofAVENTIS PHARMA GMBH·Filed 1998·Granted Jul 24, 2001·15 cites·28 claims
- 4851US2003008398A1Self-enhancing, pharmacologically controllable expression systemsFiled 2002·Application pending·0 cites
- 4950US2010239563A1Pharmaceutical composition for the prophylaxis and/or treatment of viral diseasesLUDWIG STEPHAN·Filed 2008·Application pending·0 cites
- 5050US2005129694A1Pharmaceutical composition for the prophylaxis and/or treatment of virus diseasesFiled 2002·Application pending·0 cites
Showing the top 50 of 64 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →